110810 ⎘
ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus A, i.e. influenza A virus New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
INFLUENZA POLYNUCLEOTIDES, EXPRESSION CONSTRUCTS, COMPOSITIONS, AND METHODS OF USE
#602Nucleic acids involved in viral infection
#603Avian influenza chimeric VLPS
#604Method for generation of RNA virus
#605Compositions and methods for the therapy and diagnosis of influenza
#606High-yield transgenic mammalian expression system for generating virus-like particles
#607ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#608Vaccine against pandemic strains of influenza viruses
#609Influenza inhibiting compositions and methods
#610Vaccines against influenza virus
#611Compositions and methods for increasing immunogenicity of glycoprotein vaccines
#612METHODS OF PREDICTING CANCER LETHALITY USING REPLIKIN COUNTS
#613METHODS OF ENHANCING PROTEIN INCORPORATION INTO VIRUS LIKE PARTICLES
#614NOVEL INFLUENZA M2 VACCINES
#615LENTIVIRUS PSEUDOTYPED WITH INFLUENZA HEMAGGLUTININ AND METHODS OF USE
#616Human M2e peptide immunogens
#617Functional influenza virus like particles (VLPs)
#618LINEAR EXPRESSION CONSTRUCTS FOR PRODUCTION OF INFLUENZA VIRUS PARTICLES
#619ANTI-HIV IMMUNOGENIC FORMULATION AND PROCESS FOR PREPARATION THEREOF
#620Influenza infection-inhibiting peptide, influenza virus infection inhibitor, liposome, and influenza preventive/therapeutic agent
#621Methods and reagents for vaccination which generate a CD8 T cell immune response
#622Papaya Mosaic Virus-Based Vaccines for Influenza
#623METHODS AND COMPOSITIONS FOR PREPARING A UNIVERSAL INFLUENZA VACCINE
#624Method for the preparation of sulfated cellulose membranes and sulfated cellulose membranes
#625VACCINE COMPOSITIONS OF M2e, HA0 AND BM2 MULTIPLE ANTIGENIC PEPTIDES
#626PROCESS FOR DESIGNING INHIBITORS OF INFLUENZA VIRUS STRUCTURAL PROTEIN-1
#627Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
#628PEPTIDE VACCINE FOR INFLUENZA VIRUS
#629AVIAN INFLUENZA VACCINE
#630Chimeric influenza virus-like particles
#631Method for Producing Viral Vaccine and Therapeutic Peptide Antigens
#632Methods and compositions for increasing replication capacity of an influenza virus
#633H3 equine influenza A virus
#634Peptide sequences and compositions
#635CHIMERIC VIRUS-LIKE PARTICLES
#636Flu vaccines and methods of use thereof
#637Assay for the separation and quantification of hemagglutinin antigens
#638METHODS AND COMPOSITIONS FOR PREDICTING AND TREATING DRUG RESISTANT STRAINS OF INFLUENZA VIRUS
#639VLP based vaccine delivery system
#640TARGETS FOR HUMAN MICRO RNAS IN AVIAN INFLUENZA VIRUS (H5N1) GENOME
#641Preparation of vaccine master cell lines using recombinant plant suspension cultures
#642Vaccines for the Rapid Response to Pandemic Avian Influenza
#643Recombinant Newcastle Disease Virus Expressing H5 Hemagglutinin of Avian Influenza Virus
#644Recombinant baculovirus vaccine
#645CHIMERIC VACCINE ANTIGENS AGAINST THE AVIAN INFLUENZA VIRUS
#646Method of elicting or inducing an immune response
#647Methods and reagents for vaccination which generate a CD8 T cell immune response
#648Signal for packaging of influenza virus vectors
#649Composition and Methods for Immunisation Using CD1D Ligands
#650Influenza vaccine
#651Multi plasmid system for the production of influenza virus
#652INFLUENZA NUCLEIC ACIDS, POLYPEPTIDES, AND USES THEREOF
#653METHODS AND COMPOUNDS FOR MITIGATING PATHOGENIC OUTBREAKS USING REPLIKIN COUNT CYCLES
#654Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
#655REPLIKIN PEPTIDES IN RAPID REPLICATION OF GLIOMA CELLS AND IN INFLUENZA EPIDEMICS
#656RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY
#657Avian vaccines possessing a positive marker gene
#658Assembly of wild-type and chimeric influenza virus-like particles (VLPs)
#659Influenza inhibiting compositions and methods
#660Compositions and methods for the therapy and diagnosis of influenza
#661Expression of proteins in plants
#662Virus Vaccines Comprising Envelope-Bound Immunomodulatory Proteins and Methods of Use Thereof
#663ANTIVIRAL AGENTS AND VACCINES AGAINST INFLUENZA
#664Methods for the propagation of modified influenza viruses in embryonated eggs
#665Methods and reagents for vaccination which generate A CD8 T cell immune response
#666Influenza antigen delivery vectors and constructs
#667Replikin peptides in rapid replication of glioma cells and in influenza epidemics
#668Cloned defective interfering influenza A virus
#669Fusion Protein Comprising an Fc Receptor Binding Polypeptide and an Antigenic Polypeptide for Mediating an Immune Response
#670Influenza hemagglutinin and neuraminidase variants
#671Influenza Hemagglutinin And Neuraminidase Variants
#672Method for producing temperature sensitive influenza A viruses
#673RECOMBINANT RSV VIRUS EXPRESSION SYSTEMS AND VACCINES
#674Influenza Hemagglutinin And Neuraminidase Variants
#675SYSTEM FOR RAPID PRODUCTION OF HIGH-TITER AND REPLICATION-COMPETENT ADENOVIRUS-FREE RECOMBINANT ADENOVIRUS VECTORS
#676Recombinant protein production in a human cell
#677INFLUENZA COMBINATORIAL ANTIGEN VACCINE
#678Vaccines against multiple subtypes of influenza virus
#679Compositions of influenza viral proteins and methods of use thereof
#680Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
#681Microbial vaccine and vaccine vector
#682Attenuated RNA virus and applications thereof
#683Immunogenic compositions
#684REPLIKIN PEPTIDES AND ANTIBODIES THEREFORE
#685Influenza hemagglutinin and neuraminidase variants
#686Recombinant flu vaccines
#687DNA sequences, vectors and proteins of avian influenza hemagglutinin
#688Alphavirus Vectors for Respiratory Pathogen Vaccines
#689Method to Make a Peptide-Carrier Conjugate with a High Immunogenicity
#690Peptide-Based Influenza Vaccine Formulation
#691Fusion antigen used as vaccine and method of making them
#692METHOD FOR ISOLATING HEPATITIS C VIRUS PEPTIDES
#693Immunogenic compositions and methods
#694Influenza M2 protein mutant viruses as live influenza attenuated vaccines
#695Vero cell-based influenza virus strains and vaccines
#696Peptide vaccine for influenza virus
#697Flu vaccines and methods of use thereof
#698Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#699Adenoviral vectors for influenza virus production
#700H2N3 influenza A viruses and methods of use
#701TSG101-GAG INTERACTION AND USE THEREOF
#702Canine influenza virus and related compositions and methods of use
#703Polyvalent influenza virus-like particle (VLP) compositions
#704Advanced genetic vaccines
#705Composition and method for preventing or treating a virus infection
#706COLD-ADAPTED EQUINE INFLUENZA VIRUSES
#707DNA-transfection system for the generation of infectious influenza virus
#708DNA-transfection system for the generation of infectious influenza virus
#709Defective Influenza Virus Particles
#710Disease Prevention and Vaccination Prior to Thymic Reactivation
#711Replikins and methods of identifying replikin-containing sequences
#712Recombinant protein production in a human cell
#713CANINE INFLUENZA VACCINES
#714Methods and compositions for treating IgE-mediated diseases
#715Process for Designing Inhibitors of Influenza Virus Structural Protein 1
#716DNA-transfection system for the generation of infectious influenza virus
#717Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
#718Treating immunodeficiencies by intrathymic injection of nucleotide sequences
#719Influenza vaccine formulation
#720H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
#721Immunodeficiency recombinant poxvirus
#722Vaccine Against Pandemic Strains Of Influenza Viruses
#723Methods and compositions for increasing replication capacity of an influenza virus
#724Means and methods for breaking noncovalent binding interactions between molecules
#725Transient protein expression methods
#726Influenza A virus vaccines and inhibitors
#727Identification of self and non-self antigens implicated in autoimmune disease
#728Materials and methods for respiratory disease control in canines
#729Influenza Hemagglutinin And Neuraminidase Variants
#730Influenza hemagglutinin and neuraminidase variants
#731Production of viruses, viral isolates and vaccines
#732Attenuated influenza NS1 variants
#733Multiple antigenic agents and methods for using the same
#734TARGETS FOR HUMAN MICRO RNAS IN AVIAN INFLUENZA VIRUS (H5N1) GENOME
#735Encapsidation System for Production of Recombinant Virus-Like Particles
#736Intranasal or inhalational administration of virosomes
#737Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
#738Influenza virus-like particle (VLP) compositions
#739Bacteriophage DNA vaccine vector
#740Influenza recombinant subunit vaccine
#741Pseudotyped baculovirus to stimulate immunogenicity against avian influenza
#742Methods of producing erythropoietin isoforms comprising Lewis-X structures and high sialic acid content and compositions of the same
#743Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor
#744Influenza antigens, vaccine compositions, and related methods
#745Compositions that include hemagglutinin
#746Canine influenza virus
#747Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus
#748Compositions that include hemagglutinin, methods of making and methods of use thereof
#749siRNA silencing of influenza virus gene expression
#750Use of vaccines for the treatment/prevention of the transmission of pathogens
#751Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids
#752Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier
#753MHC binding peptides and their uses
#754Cold-adapted equine influenza viruses
#755Assay for the separation and quantification of hemagglutinin antigens
#756Functional influenza virus like particles (VLPs)
#757Immunization of avians by administration of non-replicating vectored vaccines
#758Cold-adapted (CA) reassortant influenza virus
#759Cold-adapted equine influenza viruses
#760Polyepitope vaccines
#761Immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes
#762Immune responses using compositions containing stress proteins
#763Signal for packaging of influenza virus vector
#764Influenza vaccine
#765Antigens encoded by alternative reading frames from pathogenic viruses
#766Methods for generating immune responses to influenza antigens with a secretable CD40L fusion protein
#767Influenza vaccine compositions and methods of use thereof
#768INFLUENZA VACCINE COMPOSITIONS AND METHODS
#769Preparation of vaccine master cell lines using recombinant plant suspension cultures
#770Canine influenza virus and related compositions and methods of use
#771Compositions and methods for the treatment of canine influenza virus disease
#772Cold-adapted equine influenza viruses
#773Recombinant protein production in a human cell
#774Replikin peptides in rapid replication of glioma cells and in influenza epidemics
#775Canine influenza vaccines
#776Influenza recombinant subunit vaccine
#777Influenza recombinant subunit vaccine
#778Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
#779Influenza immunogen and vaccine
#780Modified influenza virus for monitoring and improving vaccine efficiency
#781Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
#782Stabilized immunogenic HBc chimer particles
#783Vaccines for the rapid response to pandemic avian influenza
#784Functional influenza virus-like particles (VLPs)
#785Vaccines
#786Influenza hemagglutinin and neuraminidase variants
#787Immunoprotective influenza antigen and its use in vaccination
#788ANTI-HIV IMMUNOGENIC FORMULATION AND PROCESS FOR PREPARATION THEREOF
#789Virosome-like-particles
#790Polypeptide transduction and fusogenic peptides
#791Influenza nucleic acids, polypeptides, and uses thereof
#792Method for isolating hepatitis C virus peptides
#793Functionally reconstituted viral membranes containing adjuvant
#794Flexible vaccine assembly and vaccine delivery platform
#795Vaccine delivery compositions and methods of use
#796Composition and method for preventing or treating a virus infection
#797Recombinant RSV virus expression systems and vaccines
#798Mouse model for autoimmune disorders
#799H3 equine influenza A virus
#800Antigenic peptides
#801System producing infectious recombinant influenza virus
#802Process for producing virus vector containing membrane protein having sialic acid-binding in envelope with the use of gram-positive bacterium origin nueraminidase
#803Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
#804Influenza immunogen and vaccine
#805Recombinant expression of factor VIII in human cells
#806Peptide delivery
#807RNA silencing in animals as an antiviral defense
#808Recombinant influenza viruses for vaccines and gene therapy
#809Assay for the separation and quantification of hemagglutinin antigens
#810System and method for identifying complex patterns of amino acids
#811Recombinant negative strand RNA virus expression system and vacccines
#812Immunization of infants
#813Molecular methods and compositions for detecting and quantifying respiratory viruses
#814Influenza hemagglutinin and neuraminidase variants
#815Influenza hemagglutinin and neuraminidase variants
#816Methods of use of viral vectors to deliver antigen to dendritic cells
#817Multi plasmid system for the production of influenza virus
#818Viruses comprising mutant ion channel protein
#819Recombinant baculovirus and virus-like particle
#820Immune responses using compositions containing stress proteins
#821Assembly of wild-type and chimeric influenza virus-like particles (VLPs)
#822DNA transfection system for the generation of infectious influenza virus
#823Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
#824Cold-adapted equine influenza viruses
#825Production of a protein delivery system for in vivo therapeutic treatment
#826Recombinant protein production in permanent amniocytic cells that comprise nucleic acid encoding adenovirus E1A and E1B proteins
#827Recombinant RSV virus expression systems and vaccines
#828Antigen presenting system and methods for activation of T-cells
#829Methods and compositions for immunotherapy of cancer
#830Production of viruses viral isolates and vaccines
#831Delivery system
#832Efficient production of IgA in recombinant mammalian cells
#833Method for generating influenza viruses and vaccines
#834Methods and interferon deficient substrates for the propagation of viruses
#835Influenza hemagglutinin and neuraminidase variants
#836DNA vaccine expressing HA1 of equine-2 influenza virus
#837Recombinant negative strand RNA virus expression systems and vaccines
#838Vaccine compositions and methods
#839Functional influenza virus-like particles (VLPs)
#840High titer recombinant influenza viruses for vaccines and gene therapy
#841Stabilized hemagglutinin (HA) trimers as influenza vaccine antigens
#842NS1/2-deficient respiratory syncytial virus and melanoma treatment